Skip to Content

CTSI Grant Helps Amplify University Research

Scientist works in lab with a petri dish

The University of Minnesota’s Clinical and Translational Science Institute (CTSI) was recently awarded one of the two largest federal grants the University has ever received: $42.6 million in renewed funding from the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences' Clinical and Translational Science Award (CTSA) program.

CTSA funding supports programs that help clinical and translational researchers and clinical research professionals across the University to accelerate their discoveries and collaborate with colleagues throughout the state to address health challenges and expand medical research.  

The previous CTSA award in 2011, totaling $51 million, funded more than 170 research projects and helped create six startup ventures: CoreBiome (pharmaceutics), Tychon Biosciences (immunotherapy), Embomedics (medical devices), Andarta Medical (biotechnology), MesoFlow (stem cell research), and Vigilant Diagnostics (diagnostics). As these technologies reach the market, Minnesotans gain access to advanced options in healthcare and a better quality of life.

Still more projects, like a diagnostic tool that will quickly and inexpensively diagnose bacterial infections, are in progress and will benefit from CTSA funding throughout the research process.

Learn more about the grant and its benefits for the University and state in the official press release.

Meher Khan

Meher Khan

Meher previously served as communications associate for the Office of the Vice President for Research. She now works in the U of M's Clinical and Translational Science Institute as a communications specialist.

Latest Blog Posts

Dr. Friedemann-Sanchez and Dr. Grieve sitting at a table together.

In 2018, two University of Minnesota researchers traveled to a United Nations council meeting to advocate for changes to address an epidemic of violence against women in Colombia.

Read More
Senior man speaks with a health care provider while looking at a digital display

Researchers aim to help train pharmacists and educate patients with the goal of improving medication outcomes for groups with higher rates of kidney failure.

Read More
Sironix banner in a laboratory space

Sironix Renewables uses a patented method to make nontoxic, sustainably-sourced surfactants that replace their counterparts made from petroleum.

Read More
Border crossing checkpoint from Mexico to US

As an expert witness on federal immigration court cases, Patrick McNamara provides insight into violence directly and indirectly related to drug cartels.

Read More